Golozar Asieh, Schoendorf Juliane
Epidemiology, Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany.
Pharmacovigilance, Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer Oy, Espoo, Finland.
Neuroophthalmology. 2018 Jul 27;43(1):67-69. doi: 10.1080/01658107.2018.1465439. eCollection 2019 Feb.
The current letter to the editor describes some of the limitations of Valenzuela et al.'s study on the association between levonorgestrel-releasing intrauterine system use and pseudotumor cerebri/idiopathic intracranial hypertension and further reinforces the authors' interpretations of the findings.
当前这封致编辑的信描述了巴伦苏埃拉等人关于左炔诺孕酮宫内节育系统使用与假性脑瘤/特发性颅内高压之间关联的研究的一些局限性,并进一步强化了作者对研究结果的解读。